Literature DB >> 34812954

Screening recall in older cancer survivors detects differences in balance and mobility.

Jennifer Blackwood1, Robert Sweeney2, Kateri Rybicki2.   

Abstract

PURPOSE: Cognitive impairments have been reported by up to two-thirds of cancer survivors whose primary cancer did not occur in the central nervous system. Physical impairments as sequelae of cancer-related cognitive impairment (CRCI) have not been well described in previous studies. Furthermore, there is scarcity of literature describing differences among physical performance in those with and without CRCI. The purpose of this study is to examine the differences in physical function of older cancer survivors based on cognitive ability to determine if physical performance differs when different cognitive screening measures are employed.
METHODS: Adults age 65 + with a history of cancer from the 2010 Health and Retirement Study (n = 1,953) were assigned to groups according to their cognitive ability. Between-group demographic, mobility, and cognitive differences were analyzed using chi-squared and t tests. Recall and orientation were used as cognitive variables, and physical performance outcomes included gait speed, balance, and grip strength.
RESULTS: Respondents with Low Recall had more impaired balance (semi-tandem, tandem) (p < .05) and slower gait speeds (p < .05). Respondents that were Not-Oriented had slower gait speed (p < .05). Between-group differences in demographics were found by recall and orientation groups.
CONCLUSIONS: Impairments in balance and gait speed are able to be detected when recall is screened in a population of older cancer survivors. When assessing how physical mobility is related to fall risk, a screen of cognition should go beyond just orientation.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cognition; Memory; Neoplasms; Orientation; Postural balance; Short-term; Walking speed

Mesh:

Year:  2021        PMID: 34812954     DOI: 10.1007/s00520-021-06705-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  41 in total

Review 1.  Chemotherapy-related cognitive dysfunction.

Authors:  Jeffrey S Wefel; Sanne B Schagen
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

2.  Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy.

Authors:  Kerri M Winters-Stone; Esther Moe; Julie N Graff; Nathan F Dieckmann; Sydnee Stoyles; Carolyn Borsch; Joshi J Alumkal; Christopher L Amling; Tomasz M Beer
Journal:  J Am Geriatr Soc       Date:  2017-03-06       Impact factor: 5.562

Review 3.  Accidental Fall Rates in Community-Dwelling Adults Compared to Cancer Survivors During and Post-Treatment: A Systematic Review With Meta-Analysis.

Authors:  Marie-Louise Bird; Michael J Cheney; Andrew D Williams
Journal:  Oncol Nurs Forum       Date:  2016-03       Impact factor: 2.172

4.  Do older adults with cancer fall more often? A comparative analysis of falls in those with and without cancer.

Authors:  Sandra L Spoelstra; Barbara A Given; Debra L Schutte; Alla Sikorskii; Mei You; Charles W Given
Journal:  Oncol Nurs Forum       Date:  2013-03       Impact factor: 2.172

5.  Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.

Authors:  Ellen L McGough; Valerie E Kelly; Rebecca G Logsdon; Susan M McCurry; Barbara B Cochrane; Joyce M Engel; Linda Teri
Journal:  Phys Ther       Date:  2011-05-26

6.  Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses.

Authors:  Todd S Horowitz; Melissa Treviño; Ingrid M Gooch; Korrina A Duffy
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

Review 7.  Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis.

Authors:  Lori J Bernstein; Graham A McCreath; Zahra Komeylian; Jill B Rich
Journal:  Neurosci Biobehav Rev       Date:  2017-10-29       Impact factor: 8.989

8.  Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Kerri M Winters-Stone; Fay Horak; Peter G Jacobs; Phoebe Trubowitz; Nathan F Dieckmann; Sydnee Stoyles; Sara Faithfull
Journal:  J Clin Oncol       Date:  2017-06-06       Impact factor: 44.544

9.  Self-reported cognitive impairment in patients with cancer.

Authors:  Sadhna Kohli; Jennifer J Griggs; Joseph A Roscoe; Pascal Jean-Pierre; Christopher Bole; Karen M Mustian; Renae Hill; Kelly Smith; Howard Gross; Gary R Morrow
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840

Review 10.  Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

Authors:  Jeanne S Mandelblatt; Arti Hurria; Brenna C McDonald; Andrew J Saykin; Robert A Stern; John W VanMeter; Meghan McGuckin; Tiffani Traina; Neelima Denduluri; Scott Turner; Darlene Howard; Paul B Jacobsen; Tim Ahles
Journal:  Semin Oncol       Date:  2013-12       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.